ImmunoGen's ovarian cancer drug fails in late-stage study

U.S. drug developer ImmunoGen Inc said on Friday its experimental ovarian cancer drug failed to meet the main goal of a late-stage study.

from Reuters: Health News https://ift.tt/2TrxjzK
via IFTTT